Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
279.31
+5.25 (1.92%)
May 2, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Revenue
In the year 2023, Bio-Rad Laboratories had annual revenue of $2.67B, a decrease of -4.67%. Revenue in the quarter ending December 31, 2023 was $681.18M, a -6.72% decrease year-over-year.
Revenue (ttm)
$2.67B
Revenue Growth
-4.67%
P/S Ratio
3.00
Revenue / Employee
$332,660
Employees
8,030
Market Cap
8.01B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.67B | -130.99M | -4.67% |
Dec 31, 2022 | 2.80B | -120.30M | -4.12% |
Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
Dec 31, 2019 | 2.31B | 22.24M | 0.97% |
Dec 31, 2018 | 2.29B | 129.26M | 5.98% |
Dec 31, 2017 | 2.16B | 91.98M | 4.45% |
Dec 31, 2016 | 2.07B | 48.73M | 2.41% |
Dec 31, 2015 | 2.02B | -155.60M | -7.15% |
Dec 31, 2014 | 2.18B | 42.35M | 1.99% |
Dec 31, 2013 | 2.13B | 63.46M | 3.07% |
Dec 31, 2012 | 2.07B | -4.29M | -0.21% |
Dec 31, 2011 | 2.07B | 146.41M | 7.60% |
Dec 31, 2010 | 1.93B | 142.87M | 8.01% |
Dec 31, 2009 | 1.78B | 19.88M | 1.13% |
Dec 31, 2008 | 1.76B | 303.31M | 20.76% |
Dec 31, 2007 | 1.46B | 187.12M | 14.69% |
Dec 31, 2006 | 1.27B | 92.95M | 7.87% |
Dec 31, 2005 | 1.18B | 90.97M | 8.35% |
Dec 31, 2004 | 1.09B | 110.38M | 11.27% |
Dec 31, 2003 | 979.63M | 114.63M | 13.25% |
Dec 31, 2002 | 865.01M | 47.50M | 5.81% |
Dec 31, 2001 | 817.51M | 91.63M | 12.62% |
Dec 31, 2000 | 725.88M | 170.49M | 30.70% |
Dec 31, 1999 | 555.40M | 107.54M | 24.01% |
Dec 31, 1998 | 447.86M | 20.95M | 4.91% |
Dec 31, 1997 | 426.91M | 8.13M | 1.94% |
Dec 31, 1996 | 418.79M | 22.17M | 5.59% |
Dec 31, 1995 | 396.62M | 41.32M | 11.63% |
Dec 31, 1994 | 355.30M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Encompass Health | 4.80B |
Masimo | 2.05B |
Exelixis | 1.85B |
Penumbra | 1.06B |
Inspire Medical Systems | 624.80M |
Intra-Cellular Therapies | 464.37M |
Ascendis Pharma | 296.35M |
Legend Biotech | 285.14M |
BIO News
- 1 day ago - Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference - Business Wire
- 6 days ago - Bio-Rad Announces Life Science Group Management Changes - Business Wire
- 14 days ago - Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - Business Wire
- 22 days ago - Bio-Rad's Chief Operating Officer Andrew Last to Retire - Business Wire
- 6 weeks ago - Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer - Business Wire
- 2 months ago - Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day - Business Wire
- 2 months ago - Bio Rad Labs rises after posting upbeat fourth-quarter profit - Reuters
- 2 months ago - Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results - Business Wire